|
|
Effect of Pidotimod on Immune and Inflammatory Factors of Children with Mycoplasma Pneumonia |
CHEN Yanling, et al |
The Affiliated Hospital to Jilin Medical College, Jilin Jilin 132023, China |
|
|
Abstract Objective: To observe the effect of pidotimod on immune and inflammatory factors of children with mycoplasma pneumonia.Methods: 80 cases of children with mycoplasma pneumonia treated in our hospital from March 2013 to July 2015 were selected and divided into control group and observation group according to random stratified grouping method, 40 cases in each group. The control group was given Azithromycin for treatment, while the observation group was given pidotimod on the basis of the treatment in the control group, then the level changes of immune function and inflammatory factors in the two groups were compared. Results: After treatment, immune function detecting indexes (IL-10,IL-6,TNF-α)in the observation group were all lower than those in the control group (t=5.731,P<0.05, inflammatory factor(CD3+,CD4+,CD8+,CD4+/CD8+)level in the observation group were all higher than those in the control group(t=5.538,P<0.05), CD8+ level in the observation group was lower than that in the control group(t=5.652,P<0.05). Conclusion: Clinical application of pidotimod for the treatment on children with mycoplasma pneumonia can improve the body's inflammatory status and immune function.
|
|
Fund:辽宁省2015年自然科学基金计划立项项目,(编号:2015020552) |
|
|
|
[1] 王冠,李开为.匹多莫德对支原体肺炎患儿免疫及炎性因子的影响[J].临床肺科杂志,2014,19(5):823~825. [2] 陈玲,覃军,胡荆江.哌拉西林舒巴坦联合阿奇霉素治疗儿童支原体肺炎的临床疗效及其对血清炎性因子水平的影响[J].实用心脑肺血管病杂志,2016,24(3):98~101. [3] 张林.超敏C反应蛋白及血常规对小儿肺炎支原体感染的临床诊断价值分析[J].临床和实验医学杂志,2014,1810):840~842. [4] 徐凯虹,周罗根,程宝金.匹多莫德辅助治疗婴幼儿支原体肺炎疗效观察及免疫功能变化[J].中南医学科学杂志,2016,44(3):299~302. [5] 马红秋,李黎,徐雍,等.肺炎支原体肺炎患儿免疫功能变化及匹多莫德对其治疗作用[J].中华实用儿科临床杂志,2010,25(22):1703~1704. |
|
|
|